HomeCompareAPAJF vs MRK

APAJF vs MRK: Dividend Comparison 2026

APAJF yields 5.55% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $31.5K in total portfolio value· pulled ahead in Year 2
10 years
APAJF
APAJF
● Live price
5.55%
Share price
$6.85
Annual div
$0.38
5Y div CAGR
-8.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$280.80
Full APAJF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — APAJF vs MRK

📍 MRK pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPAJFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APAJF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
APAJF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APAJF
Annual income on $10K today (after 15% tax)
$471.48/yr
After 10yr DRIP, annual income (after tax)
$238.68/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,089.73/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APAJF + MRK for your $10,000?

APAJF: 50%MRK: 50%
100% MRK50/50100% APAJF
Portfolio after 10yr
$41.0K
Annual income
$5,039.47/yr
Blended yield
12.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

APAJF
Analyst Ratings
1
Hold
Consensus: Hold
Price Target
$9.00
+31.4% upside vs current
Range: $9.00 — $9.00
Altman Z
1.2
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APAJF buys
0
MRK buys
0
No recent congressional trades found for APAJF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPAJFMRK
Forward yield5.55%2.76%
Annual dividend / share$0.38$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-8.8%32.7%
Portfolio after 10y$25.3K$56.8K
Annual income after 10y$280.80$9,798.13
Total dividends collected$3.9K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$9.00$128.54

Year-by-year: APAJF vs MRK ($10,000, DRIP)

YearAPAJF PortfolioAPAJF Income/yrMRK PortfolioMRK Income/yrGap
1$11,206$505.87$11,206$366.19$0.00MRK
2← crossover$12,473$483.17$12,650$502.35$177.00MRK
3$13,805$458.41$14,407$694.19$602.00MRK
4$15,204$432.43$16,585$967.82$1.4KMRK
5$16,674$405.92$19,342$1,363.89$2.7KMRK
6$18,221$379.43$22,913$1,947.19$4.7KMRK
7$19,849$353.40$27,662$2,823.89$7.8KMRK
8$21,567$328.15$34,159$4,173.35$12.6KMRK
9$23,381$303.89$43,337$6,308.80$20.0KMRK
10$25,298$280.80$56,776$9,798.13$31.5KMRK

APAJF vs MRK: Complete Analysis 2026

APAJFStock

APA Group engages in energy infrastructure business in Australia. The company operates through three segments: Energy Infrastructure, Asset Management, and Energy Investments. It operates natural gas pipelines, electricity interconnectors, gas fired power generation stations, and solar farms and wind farms, as well as gas storage, processing, and compression facilities. The company has interests in approximately 15,000 kilometers of gas transmission pipelines; approximately 29,500 kilometers of gas mains and pipelines; and 1.4 million gas consumer connections. It also provides commercial, operating, and asset maintenance services to its energy investments and third parties; and invests in unlisted entities. The company was incorporated in 2007 and is headquartered in Sydney, Australia.

Full APAJF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this APAJF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APAJF vs SCHDAPAJF vs JEPIAPAJF vs OAPAJF vs KOAPAJF vs MAINAPAJF vs JNJAPAJF vs ABBVAPAJF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.